|
|
|
|
Ultrasound Tracks Icatibant Effects in Osteoarthritis
_ Ultrasound Tracks Icatibant Effects in Osteoarthritis.
|
|
|
Isolated Tears of the Anterior Cruciate Ligament: Over 30-Year Follow-up of Patients Treated With Arthrotomy a
Isolated Tears of the Anterior Cruciate Ligament Over 30-Year Follow-up of Patients Treated With Arthrotomy and Primary Repair COL (ret) Dean C.Taylor, MD*,, CPT Matthew Posner, MD, COL (ret) Walton W. Curl, MD and COL (ret) John A.
|
|
|
Wnt signaling and Osteoarthritis
Click the title below to leave the MDLinx Network and go to the Journal's Website Bone , 12/31/08 Print Save in My Library Free Abstract Luyten FP et al.- Studies in developmental, genetic and joint disease models indicate that Wnt...
|
|
|
TopAbstracts in Osteoarthritis 12/25/2008
TopAbstracts in Osteoarthritis are the abstracts most highly rated/most read by nearly 300,000 physicians who received a Doctor's Guide newsletter or visited a website Powered by Doctor's Guide in the past 14 days.Over 2000 peer...
|
|
|
Companies Get Good News From Osteoarthritis Study
CrystalGenomics and CG Pharmaceuticals received positive results from a Phase IIa study of CG100649 as a treatment for osteoarthritis.A high dose of the drug met the studys primary endpoint, showing greater improvement compared with...
|
|
|
Galapagos and GlaxoSmithKline Expand Osteoarthritis Alliance
- Galapagos NV (Euronext: GLPG) announced today that it has expanded the osteoarthritis alliance with GlaxoSmithKline (GSK) to include two additional drug targets.For this expansion, Galapagos receives a payment from GSK of 2 million cash...
|
|
|
Galapagos and GlaxoSmithKline expand osteoarthritis alliance
Mechelen, Belgium Galapagos NV (Euronext: GLPG) announced today that it has expanded the osteoarthritis alliance with GlaxoSmithKline (GSK) to include two additional drug targets.For this expansion, Galapagos receives a payment from GSK...
|
|
|
CrystalGenomics Announces Positive Phase IIa Results For Osteoarthritis Study Of CG100649
CrystalGenomics, Inc.(Seoul, Korea) and CG Pharmaceuticals, Inc. (Emeryville, CA) announced positive results from a Phase IIa osteoarthritis (OA) study of the efficacy and safety of a next-generation NSAID, CG100649. The CG100649...
|
|
|
One in three Gulf residents suffers from Arthritis, Pfizer reports
More than one in three Gulf residents suffers from chronic arthritic joint pain, with the prevalence of the condition increasing from 30% in 45 year olds to 60% in 65 year olds, according to medical experts in the region.Osteoarthritis...
|
|
|
Galapagos NV and GlaxoSmithKline (GSK) (JOBS) Expand Osteoarthritis Alliance
-- Galapagos NV (Euronext: GLPG) announced today that it has expanded the osteoarthritis alliance with GlaxoSmithKline (GSK) to include two additional drug targets.For this expansion, Galapagos receives a payment from GSK of EUR 2 million...
|
|
|
Galapagos NV and GlaxoSmithKline (GSK) Expand Osteoarthritis Alliance
-- Galapagos NV (Euronext: GLPG) announced today that it has expanded the osteoarthritis alliance with GlaxoSmithKline (GSK) to include two additional drug targets.For this expansion, Galapagos receives a payment from GSK of EUR 2 million...
|
|
|
BRIEF-Galapagos, GlaxoSmithKline expand osteoarthritis alliance
BRUSSELS, Dec 22 (Reuters) - Galapagos NV: GALAPAGOS AND GLAXOSMITHKLINE EXPAND OSTEOARTHRITIS ALLIANCE.FOR THIS EXPANSION, GALAPAGOS RECEIVES A PAYMENT FROM GSK OF 2 MILLION EUROS CASH. THIS PAYMENT IS IN ADDITION TO THE EXISTING...
|
|
|
Galapagos and GlaxoSmithKline Expand Osteoarthritis Alliance
ADMET.net| BioInformatics.net | ClinicalTrials.net | CombiChem.net | ePosters.net | GenomicsProteomics.com | HighThroughputExperimentation.com | HTScreening.net | Lab-on-a-Chip.com | MarketReports.com | MassSpec.net | Metabolomics.net |...
|
|
|
Frankincense Provides Relief for Osteoarthritis; New Article in BMJ December Issue
PL Thomas (PLT), in alliance with Laila Nutra, India, today jointly announced the publication of an article in BMJs December 17 issue titled Frankincense: Systematic Review, in which the patent-pending Boswellia serrata extract 5-LOXIN was...
|
|
|
Galapagos and GlaxoSmithKline Expand Osteoarthritis Alliance
- Galapagos NV (Euronext: GLPG) announced today that it has expanded the osteoarthritis alliance with GlaxoSmithKline (GSK) to include two additional drug targets.For this expansion, Galapagos receives a payment from GSK of 2 million cash...
|
|
|
Galapagos and GlaxoSmithKline expand osteoarthritis alliance
Galapagos NV (Euronext: GLPG) announced today that it has expanded the osteoarthritis alliance with GlaxoSmithKline (GSK) to include two additional drug targets.For this expansion, Galapagos receives a payment from GSK of EUR 2 million...
|
|
|
Galapagos and GlaxoSmithKline expand osteoarthritis alliance
Galapagos NV (Euronext: GLPG) announced today that it has expanded the osteoarthritis alliance with GlaxoSmithKline (GSK) to include two additional drug targets.For this expansion, Galapagos receives a payment from GSK of EUR 2 million...
|
|
|
Galapagos and GlaxoSmithKline expand osteoarthritis alliance
MECHELEN, BELGIUM -- (Marketwire) -- 12/22/08 -- Galapagos NV (Euronext: GLPG) announced today that it has expanded the osteoarthritis alliance with GlaxoSmithKline (GSK) to include two additional drug targets.For this expansion,...
|
|
|
Galapagos and GlaxoSmithKline expand osteoarthritis alliance
(Hugin via COMTEX) -- GSK | Quote | Chart | News | PowerRating -- Mechelen, Belgium; 22 December 2008 - Galapagos NV (Euronext: GLPG) announced today that it has expanded the osteoarthritis alliance with GlaxoSmithKline (GSK) to include two...
|
|
|
Galapagos and GlaxoSmithKline expand osteoarthritis alliance
- Galapagos NV (Euronext: GLPG) announced today that it has expanded the osteoarthritis alliance with GlaxoSmithKline (GSK) to include two additional drug targets.For this expansion, Galapagos receives a payment from GSK of 2 million cash...
|
|
|
Galapagos and GlaxoSmithKline expand osteoarthritis alliance
MECHELEN, BELGIUM -- (MARKET WIRE) -- 12/22/08 -- Galapagos NV (Euronext: GLPG) announced today that it has expanded the osteoarthritis alliance with GlaxoSmithKline (GSK) to include two additional drug targets.For this expansion,...
|
|
|
Galapagos and GlaxoSmithKline expand osteoarthritis alliance
-- Galapagos NV (Euronext: GLPG) announced today that it has expanded the osteoarthritis alliance with GlaxoSmithKline (GSK) to include two additional drug targets.For this expansion, Galapagos receives a payment from GSK of EUR 2 million...
|
|
|
Galapagos and GlaxoSmithKline expand osteoarthritis alliance
(MARKET WIRE via COMTEX) -- Galapagos NV (Euronext: GLPG) announced today that it has expanded the osteoarthritis alliance with GlaxoSmithKline (GSK) to include two additional drug targets.For this expansion, Galapagos receives a payment...
|
|
|
Galapagos and GlaxoSmithKline expand osteoarthritis alliance
2008-12-2201:31ET - News Release MECHELEN, BELGIUM -- (MARKET WIRE) -- 12/22/08 Galapagos NV (Euronext: GLPG) announced today that it has expanded the osteoarthritis alliance with GlaxoSmithKline (GSK) to include two additional drug targets....
|
|
|
Galapagos and GlaxoSmithKline expand osteoarthritis alliance
Galapagos NV (Euronext: GLPG) announced today that it has expanded the osteoarthritis alliance with GlaxoSmithKline (GSK) to include two additional drug targets.For this expansion, Galapagos receives a payment from GSK of EUR 2 million...
|
